The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Self-citationNoman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Highfill, S. L., Cui, Y., Giles, A. J., Smith, J. P., Zhang, H., Morse, E., Kaplan, R. N., & Mackall, C. L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007974 · Cited by 767
Self-citationMechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., & Gabrilovich, D. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900092 · Cited by 763
The mechanism of action of BCG therapy for bladder cancer--a current perspective
Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.15 · Cited by 729
Wu, P., Wu, D., Ni, C., Ye, J., Chen, W., Hu, G., Wang, Z., Wang, C., Zhang, Z., Xia, W., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.013 · Cited by 608
Yu, J., Du, W., Yan, F., Wang, Y., Li, H., Cao, S., Yu, W., Shen, C., Liu, J., & Ren, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201449 · Cited by 606
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Ozao-Choy, J., Ma, G., Kao, J., Wang, G. X., Meseck, M., Sung, M., Schwartz, M., Divino, C. M., Pan, P.-Y., & Chen, S.-H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4709 · Cited by 538
Cui, T. X., Kryczek, I., Zhao, L., Zhao, E., Kuick, R., Roh, M. H., Vatan, L., Szeliga, W., Mao, Y., Thomas, D. G., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.025 · Cited by 427
Chun, E., Lavoie, S., Michaud, M., Gallini, C. A., Kim, J., Soucy, G., Odze, R., Glickman, J. N., & Garrett, W. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.024 · Cited by 402
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Huang, B., Lei, Z., Zhao, J., Gong, W., Liu, J., Chen, Z., Liu, Y., Li, D., Yuan, Y., Zhang, G.-M., et al. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.012 · Cited by 349
Miller, L. S., O'Connell, R. M., Gutierrez, M. A., Pietras, E. M., Shahangian, A., Gross, C. E., Thirumala, A., Cheung, A. L., Cheng, G., & Modlin, R. L. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.011 · Cited by 348
Talmadge, J. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0182 · Cited by 285
Epithelial-mesenchymal transition in gastric cancer.
Huang, L., Wu, R., & Xu, A. (2015) · PubMed · Cited by 283
Wang, L., Chang, E. W. Y., Wong, S. C., Ong, S.-M., Chong, D. Q. Y., & Ling, K. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202088 · Cited by 251
Circulating and tumor‐infiltrating myeloid cell subsets in patients with bladder cancer
Eruslanov, E., Neuberger, M., Daurkin, I., Perrin, G. Q., Algood, C., Dahm, P., Rosser, C., Vieweg, J., Gilbert, S. M., & Kusmartsev, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.26123 · Cited by 205
Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
Kotsakis, A., Harasymczuk, M., Schilling, B., Georgoulias, V., Argiris, A., & Whiteside, T. L. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.04.004 · Cited by 199
Mao, Y., Poschke, I., Wennerberg, E., Pico de Coaña, Y., Egyhazi Brage, S., Schultz, I., Hansson, J., Masucci, G., Lundqvist, A., & Kiessling, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4115 · Cited by 192
OuYang, L.-Y., Wu, X.-J., Ye, S.-B., Zhang, R.-X., Li, Z.-L., Liao, W., Pan, Z.-Z., Zheng, L.-M., Zhang, X.-S., Wang, Z., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0410-7 · Cited by 189
Self-citationCXCR2‐mediated tumor‐associated neutrophil recruitment is regulated by IFN‐β
Jablonska, J., Wu, C. ‐., Andzinski, L., Leschner, S., & Weiss, S. (2014) · International Journal of Cancer · doi:10.1002/ijc.28551 · Cited by 179
Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer
Dubeykovskaya, Z., Si, Y., Chen, X., Worthley, D. L., Renz, B. W., Urbanska, A. M., Hayakawa, Y., Xu, T., Westphalen, C. B., Dubeykovskiy, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10517 · Cited by 169
Fang, L., Izumi, K., Lai, K.-P., Liang, L., Li, L., Miyamoto, H., Lin, W., & Chang, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3228 · Cited by 159
Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H., & Arbeit, J. M. (2008) · Blood · doi:10.1182/blood-2007-10-115758 · Cited by 156
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
Raval, R. R., Sharabi, A. B., Walker, A. J., Drake, C. G., & Sharma, P. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-14 · Cited by 141
Shang, K., Bai, Y., Wang, C., Wang, Z., Gu, H.-Y., Du, X., Zhou, X.-Y., Zheng, C.-L., Chi, Y.-Y., Mukaida, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051848 · Cited by 132
Thummuri, D., Jeengar, M. K., Shrivastava, S., Nemani, H., Naik, R. R., Chaudhari, P. R., & Naidu, V. G. M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.006 · Cited by 125
Winner, M. G., Koong, A. C., Rendon, B. E., Zundel, W., & Mitchell, R. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3292 · Cited by 121
Santegoets, S. J. A. M., Stam, A. G. M., Lougheed, S. M., Gall, H. E., Jooss, K. U., Sacks, N., Hege, K. M., Lowy, I., Scheper, R. J., Gerritsen, W. R., et al. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-014-0031-3 · Cited by 110
TSU68 Prevents Liver Metastasis of Colon Cancer Xenografts by Modulating the Premetastatic Niche
Yamamoto, M., Kikuchi, H., Ohta, M., Kawabata, T., Hiramatsu, Y., Kondo, K., Baba, M., Kamiya, K., Tanaka, T., Kitagawa, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1748 · Cited by 105
Li, Z.-L., Ye, S., OuYang, L.-Y., Zhang, H., Chen, Y.-S., He, J., Chen, Q.-Y., Qian, C.-N., Zhang, X.-S., Cui, J., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1044712 · Cited by 101
Self-citationMyeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
Veirman, K. D., Valckenborgh, E. V., Lahmar, Q., Geeraerts, X., Bruyne, E. D., Menu, E., Riet, I. V., Vanderkerken, K., & Ginderachter, J. A. V. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00349 · Cited by 97
Zhang, H., Li, Z.-L., Ye, S., OuYang, L.-Y., Chen, Y.-S., He, J., Huang, H.-Q., Zeng, Y.-X., Zhang, X.-S., & Li, J. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1765-6 · Cited by 97
Self-citationHong, E., Chang, S., Lee, B., Kim, Y., Lee, J., Kang, C., Kweon, M., & Ko, H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27974 · Cited by 64
Weiss, J. M., Subleski, J. J., Back, T., Chen, X., Watkins, S. K., Yagita∥, H., Sayers, T. J., Murphy, W. J., & Wiltrout, R. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400404 · Cited by 61
Role of inflammation and inflammatory mediators in colorectal cancer.
DuBois, R. N. (2014) · Europe PMC (PubMed Central) · Cited by 55
Jiang, J., Guo, W., & Liang, X. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.09.025 · Cited by 55
Huang, J., Tsai, Y.-C., Chang, Y., Wu, J.-C., Hung, J., Lin, K., Wong, C., & Yu, A. L.-T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302623 · Cited by 55
The future of bladder cancer care in the USA
Kaplan, A. L., Litwin, M. S., & Chamie, K. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.180 · Cited by 49
Mitchell, D., & Olive, C. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.04.004 · Cited by 38
Shaping of an effective immune microenvironment to and by cancer cells
Becht, É., Goc, J., Germain, C., Giraldo, N. A., Dieu‐Nosjean, M., Sautès‐Fridman, C., & Fridman, W. H. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1590-3 · Cited by 35
Stromal-dependent tumor promotion by MIF family members
Mitchell, R. A., & Yaddanapudi, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.012 · Cited by 21
ROR1C Regulates Differentiation of Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., & Nefedova, Y. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.007 · Cited by 17
Influential Factors and Synergies for Radiation-Gene Therapy on Cancer
Lin, M., Huang, J., Shi, Y., Xiao, Y., & Guo, T. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/313145 · Cited by 4
Cited by
Myeloid-derived suppressor cells coming of age
Veglia, F., Perego, M., & Gabrilovich, D. (2018) · Nature Immunology · doi:10.1038/s41590-017-0022-x · Cited by 1,767
Loeuillard, E., Yang, J., Buckarma, E., Wang, J., Liu, Y., Conboy, C., Pavelko, K. D., Li, Y., O’Brien, D., Wang, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137110 · Cited by 369
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Cheng, Y., Ma, X.-L., Wei, Y.-Q., & Wei, X.-W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.005 · Cited by 344
Tumor-associated neutrophils and neutrophil-targeted cancer therapies
Que, H., Fu, Q., Lan, T., Tian, X., & Wei, X. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188762 · Cited by 312
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape
de Jong, M. M. E., Kellermayer, Z., Papazian, N., Tahri, S., Hofste op Bruinink, D., Hoogenboezem, R., Sanders, M. A., van de Woestijne, P. C., Bos, P. K., Khandanpour, C., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00931-3 · Cited by 250
Metadata
- Authors
- Zhang, H., Ye, Y.-L., Li, M.-X., Ye, S.-B., Huang, W.-R., Cai, T.-T., He, J., Peng, J.-Y., Duan, T.-H., Cui, J., Zhang, X.-S., Zhou, F.-J., Wang, R.-F., & Li, J.
- Venue
- Oncogene
- Published
- 2016-10-10
- Volume
- 36
- Issue
- 15
- Pages
- 2095-2104
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2531373072
- Cited by
- 278
- References
- 44
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.